Dimensional Fund Advisors LP Oncocyte Corp Transaction History

Dimensional Fund Advisors LP

  • $403 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.86 - $1.53 $86,199 - $153,354
-100,232 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$1.15 - $2.25 $7,427 - $14,532
-6,459 Reduced 6.05%
100,232 $149,000
Q4 2021

Feb 09, 2022
SELL
$2.04 - $3.59 $295,192 - $519,480
-144,702 Reduced 57.56%
106,691 $232,000
Q3 2021

Nov 12, 2021
BUY
$3.53 - $5.89 $448,101 - $747,682
126,941 Added 102.0%
251,393 $895,000
Q2 2021

Aug 12, 2021
BUY
$3.77 - $6.0 $469,184 - $746,712
124,452 New
124,452 $714,000

Others Institutions Holding OCX

# of Institutions
3
Shares Held
411K
Call Options Held
0
Put Options Held
0
View Full List

About Oncocyte Corp

OCX Quotes by TradingView
  • Ticker OCX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,609,000
  • Market Cap $318M
  • Description
  • OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....
More about OCX
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email